VKTX
USDViking Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$36.740
고가
$38.000
저가
$34.615
거래량
3.77M
기업 기본 정보
시가총액
3.9B
산업
생명공학
국가
United States
거래 통계
평균 거래량
6.60M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Canaccord Genuity Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $106
Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics with a Buy rating and announces Price Target of $106.
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $75
JP Morgan analyst Hardik Parikh maintains Viking Therapeutics with a Overweight and lowers the price target from $80 to $75.
Morgan Stanley Maintains Overweight on Viking Therapeutics, Raises Price Target to $102
Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics with a Overweight and raises the price target from $98 to $102.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
